Well, I disagree. It is their choice to pair with a peer-reviewed article. It is not a requirement. Most P3 results are announced without and article or only have one come out later. The historical trial comparables are known. Easily added to tables. Our scientific review board and trial investigators have had the data for along time, IMO. They get it far before they hand it over to a Journal.
Biosect, so are you thinking they are still in the process of writing the technical paper? If so then we should expect to hear results in 2022 and start the bla process mid to late 2022 - correct?